Clinical Trial

A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China

Study acronym: 611
Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 27, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
The main purpose of this study is to compare two different formulations (mixtures) of 611 in healthy participants. This study will compare how much of each formulation gets into the blood stream.
Trial Details
NCT Number NCT07042113
Lead Sponsor Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions Atopic Dermatitis
Enrollment 180 participants
Start Date 2025-07
Primary Completion 2026-01 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-27